Molecular analysis of cystic fibrosis patients in Hungary - An update to the mutational spectrum

Gergely Ivády, Katalin Koczok, Laszlo Madar, Eva Gombos, Izabella Toth, Klaudia Gyori, István Balogh

Research output: Contribution to journalArticle

8 Citations (Scopus)


Background: In this study the authors present an update to the CFTR mutation profile in Hungary, utilizing data from a selected cohort of 45 cystic fibrosis (CF) patients from different regions of the country.

Methods: Depending on the preceding analysis, four different mutation detection methods were used. A commercial assay targeting the most common CF-causing mutations was performed as the first test followed by an allele specific PCR for CFTRdele2,3(21kb), Sanger sequencing and MLPA analysis of the coding region of the CFTR gene.

Results: In our recent study 27 different mutations were detected, including 2 novel ones (c.1037-1038insA and c.1394C>T). Besides F508del (c.1521-1523delCTT), the following mutations were found at a frequency of ≥ 4.0%: W1282X (c.3846G>A), N1303K (c.3909C>G), CFTRdele2,3(21kb) (c.54-5940-273+10250del21kb) and 2184insA (c.2052-2053insA). In addition, four mutations (G542X, Y1092X, 621+1G>T, and 2143delT) were found in more than one allele.

Conclusion: The updated database of Hungarian mutations not only enables to increase the efficiency of the existing diagnostic approach, but also provides a further refined basis for the introduction of the molecular newborn screening (NBS) program in Hungary.

Original languageEnglish
Pages (from-to)46-51
Number of pages6
JournalJournal of Medical Biochemistry
Issue number1
Publication statusPublished - Oct 8 2014


  • cystic fibrosis
  • mutational spectrum
  • newborn screening

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint Dive into the research topics of 'Molecular analysis of cystic fibrosis patients in Hungary - An update to the mutational spectrum'. Together they form a unique fingerprint.

  • Cite this